Fig. 3.

DMG is a heterogeneous tumor with diverse treatment modalities. The mainstay of treatment for DMG is fractionated RT with intermittent chemotherapy. Emerging immunotherapies, such as vaccines, oncolytic viruses, checkpoint inhibitors, and pharmacologic inhibitors, have been met with preclinical success and are undergoing clinical trials.